EUVIMEDEUVIMED entdecken
Crossref

Continuous kidney replacement therapy for management of hyperammonemia and hepatic encephalopathy in pediatric acute liver failure

Bikrant Bihari Lal, Tamoghna Biswas, Vikrant Sood, Hari Shankar Meshram, Chandani Bhagat, Rajeev Khanna, Rajendra Prasad Mathur, Seema Alam iD

Journal of Pediatric Gastroenterology and Nutrition · 2025

DOI: 10.1002/jpn3.70226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2025. Verfasst von Bikrant Bihari Lal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Hyperammonemia, Hepatic Encephalopathy, Liver Failure, Acute, Continuous Renal Replacement Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to evaluate the impact of continuous kidney replacement therapy (CKRT) on the outcomes of pediatric acute liver failure (PALF).

Methods

This was a retrospective analysis of PALF presenting to a tertiary care pediatric hepatology center between January 2012 and August 2024. Cases of PALF where CKRT was initiated within 24 h of admission for nonrenal indications (hyperammonemia, hepatic encephalopathy [HE]) were identified and outcomes compared to a propensity‐matched cohort of controls not receiving CKRT. The primary outcome measures were native liver survival (NLS) and overall survival (OS) at Day 28.

Results

A total of 448 patients with PALF were admitted during the study period, of which 94 had received CKRT. Thirty‐eight (40.4%) of them who received CKRT for renal indications were excluded. The remaining 56 (59.6%) received CKRT for hyperammonemia and HE. The NLS in the CKRT and no CKRT groups were 46.4%, and 52.1%, respectively, while the OS in the two groups was 53.6%, and 61.3%, respectively. In the propensity‐matched cohort (52 in each arm), there was a statistically insignificant trend toward higher NLS (46.2% vs. 36.5%, p = 0.304) and OS (53.8% vs. 44.2%, p = 0.291) in CKRT group compared to controls. Patients receiving CKRT had lower ammonia ( p = 0.016) and bilirubin ( p = 0.008) levels on Day 4, while international normalized ratio and lactate levels remained comparable.

Conclusion

CKRT led to significant reduction in ammonia on Day 4 in PALF; however, this did not translate into improved NLS and OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperammonemiaHepatic EncephalopathyLiver Failure, AcuteContinuous Renal Replacement TherapyHumansRetrospective StudiesMaleFemaleChild, PreschoolChildInfantTreatment OutcomeAdolescent

Stichwörter der Autor:innen

CRRTcontinuous renal replacement therapyextracorporeal liver supporthemodialysisliver transplantation

Autor:innen und Institutionen

  • Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Department of Nephrology, Institute of Liver and Biliary Sciences, New Delhi, India.

ORCID-Profile: Seema Alam

Förderung

  • None

Zitieren

APA

Lal, B. B., Biswas, T., Sood, V., Meshram, H. S., Bhagat, C., Khanna, R., Mathur, R. P., & Alam, S. (2025). Continuous kidney replacement therapy for management of hyperammonemia and hepatic encephalopathy in pediatric acute liver failure. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70226

Vancouver

Lal BB, Biswas T, Sood V, Meshram HS, Bhagat C, Khanna R, et al. Continuous kidney replacement therapy for management of hyperammonemia and hepatic encephalopathy in pediatric acute liver failure. Journal of Pediatric Gastroenterology and Nutrition. 2025. doi:10.1002/jpn3.70226

BibTeX
@article{Lal2025,
  author = {Lal, Bikrant Bihari and Biswas, Tamoghna and Sood, Vikrant and Meshram, Hari Shankar and Bhagat, Chandani and Khanna, Rajeev and Mathur, Rajendra Prasad and Alam, Seema},
  title = {Continuous kidney replacement therapy for management of hyperammonemia and hepatic encephalopathy in pediatric acute liver failure},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2025},
  doi = {10.1002/jpn3.70226}
}
Kostenlos starten →